Transaction DateRecipientSharesTypePriceValue
24th February 2021Joshua Silverman42,000Grant/award etc.$0.00
1st February 2021Billy Joe White45,440Payment by withholding$12.04$547,097.60
1st February 2021Billy Joe White29,140Exercise of derivative$1.01$29,431.40
8th December 2020Bay Capital Management Lp Hudson710,000Other acquisition or disposition$10.88$7,724,800.00
7th December 2020Bay Capital Management Lp Hudson50,000Open or private sale$11.51$575,500.00
1st December 2020Joshua Silverman20,000Grant/award etc.$0.00
1st December 2020Joshua Silverman100,000Sale back to the issuer$0.00
2nd November 2020Bay Capital Management Lp Hudson50,000Open or private sale$10.87$543,500.00
16th October 2020Joshua Silverman50,000Open or private purchase$1.09$54,445.00
16th October 2020Bay Capital Management Lp Hudson1,601,100Other acquisition or disposition$10.30$16,491,330.00
Akers Biosciences
Akers Biosciences logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.

Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products. The company was founded by Raymond Francis Akers, Jr. and Raymond F.Akers, Sr. on March 8, 1989.

Ticker: AKER
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1321834
Employees: 12
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags